Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) insider Francis Burrows sold 1,311 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. Francis Burrows also recently made the following trade(s):Get Kura Oncology alerts:On Thursday, December 18th, Francis Burrows sold 23,726 shares of Kura Oncology stock. Kura Oncology Price PerformanceKURA opened at $8.04 on Thursday. Kura Oncology Company Profile(Get Free Report)Kura Oncology, Inc (NASDAQ: KURA) is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted oncology therapies. Further ReadingReceive News & Ratings for Kura Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kura Oncology and related companies with MarketBeat.com's FREE daily email newsletter.